← SynDRA
IZORLISIB
SynDRA canonical compound SYN0026416 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | MTOR | PIK3CA | PIK3CB | PIK3CD | PIK3CG |
|---|
| Mechanism of action | PI3K inhibitor |
|---|
All known targets
- PIK3CA
- PIK3CB
- PIK3CD
- PIK3CG
- MTOR
Mechanisms of action (all sources)
- MTOR inhibitor
- PIK3CA INHIBITOR
- PIK3CB INHIBITOR
- PIK3CD INHIBITOR
- PIK3CG INHIBITOR
- PI3K inhibitor
- PIK3CG MODULATOR
Cross-references
Synonyms
- CH-5132799
- PA-799
- CH5132799
- CH5132799-000
- PA799
- MEN1611
- CH-5033855
- CH-5061565
- CH-5089788
- CH-5108135
- CH-5111436
- CH-5138134
- CH 5132799
- 5-(7-(methylsulfonyl)-2-morpholino-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrimidin-2-amine
- CHEMBL1684984
- CH5132799 (PA-799)
- JCL936W835
- 5-(7-Methanesulfonyl-2-Morpholin-4-Yl-6,7-Dihydro-5h-Pyrrolo[2,3-D]pyrimidin-4-Yl)-Pyrimidin-2-Ylamine
- (5-(7-Methylsulfonyl-2-(morpholin-4-yl)-6,7-dihydro-5H-pyrrolo(2,3-d)pyrimidin-4-yl)pyrimidin-2-yl)amine
- UNII-JCL936W835
- 5-(7-methylsulfonyl-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl)pyrimidin-2-amine
- IZORLISIB [INN]
- MLS006010989
- GTPL7743
- SCHEMBL2377154
- DTXSID40678540
- EX-A997
- HMS3656H15
- HMS3750I19
- BCP02894
- MEN-1611
- BDBM50338197
- MFCD22419020
- NSC762382
- NSC800984
- s2699
- ZINC66074200
- AKOS025404886
Look up IZORLISIB in the interactive SynDRA portal →